Does BREXPIPRAZOLE Cause Off label use? 937 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 937 reports of Off label use have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 7.1% of all adverse event reports for BREXPIPRAZOLE.
937
Reports of Off label use with BREXPIPRAZOLE
7.1%
of all BREXPIPRAZOLE reports
18
Deaths
103
Hospitalizations
How Dangerous Is Off label use From BREXPIPRAZOLE?
Of the 937 reports, 18 (1.9%) resulted in death, 103 (11.0%) required hospitalization, and 2 (0.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 937 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
Depression (413)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BREXPIPRAZOLE Alternatives Have Lower Off label use Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE